Latest News
| First Patient Enrolled and Treated in the U.S. for EndoGastric Solutions' Randomized Study of TIF |
| June 23, 2011 |
| Redwood City, CA (June 23, 2011) — EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the first patient has been enrolled and treated in the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial). |
| EndoGastric Solutions Announces Key Patent Issued for TIF Procedure and EsophyX Technology |
| May 17, 2011 |
| Redwood City, CA (May 17, 2011) — EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent covering its Transoral Incisionless Fundoplication (TIF) procedure and EsophyX® device for reconstruction of the gastroesophageal junction. |
| EndoGastric Solutions Names Michael Kleine as President and Chief Executive Officer |
| May 2, 2011 |
| Redwood City, CA (May 2, 2011) — EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), announced today that the Board of Directors has appointed R. Michael (Mike) Kleine as the company’s President and Chief Executive Officer (CEO). |
| American Society of General Surgeons (ASGS) Issues Position Statement Supporting Transoral Fundoplication for Select GERD Patients |
| April 26, 2011 |
| Redwood City, CA (April 26, 2011) — EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the Transoral Incisionless Fundoplication (TIF) procedure received a significant expanded presence at the 2011 SAGES Annual Meeting Scientific Session and Postgraduate Course in San Antonio, Texas. |
| Transoral Fundoplication Has Expanded Presence at 2011 SAGES Annual Meeting |
| April 20, 2011 |
| Redwood City, CA (March 11, 2011) — EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the Transoral Incisionless Fundoplication (TIF) procedure received a significant expanded presence at the 2011 SAGES Annual Meeting Scientific Session and Postgraduate Course in San Antonio, Texas. |
| EndoGastric Solutions Recognized in Wall Street Journal's "Next Big Thing" Top 50 Venture Capital-Funded Companies |
| March 11, 2011 |
| Redwood City, CA (March 11, 2011) — EndoGastric Solutions, the leader in the emerging field of Natural Orifice Surgery (NOS), announced today that is has received the distinction of being named one of the Wall Street Journal’s “The Next Big Thing” Top 50 venture capital-funded companies in America. EndoGastric Solutions was the third highest ranking medical device company and one of only |
| TIF Procedure Featured on ABC's Good Morning America |
| February 25, 2011 |
| Redwood City, CA (February 25, 2011) — EndoGastric Solutions' Transoral Incisionless Fundoplication (TIF) procedure was featured today in a segment entitled "Cure Acid Reflux, New Non-Invasive Surgery" on ABC's Good Morning America Health. Los Angeles general surgeon Carson Liu, MD (Santa Monica, CA), presented TIF as a safe and effective non-invasive surgical treatment for |
| EGS Announces Significant Expansion of U.S. Data Supporting Transoral Fundoplication |
| February 17, 2011 |
| Redwood City, CA (February 17, 2011) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), announced that three clinical studies on transoral fundoplication have been published over the past four months. The addition of over 185 patients to the literature substantially increases the evidence supporting the safety and effectiveness of the |
| EGS Announces Second Annual Advanced Techniques in Transoral Fundoplication CME Course |
| January 26, 2011 |
| Redwood City, CA (January 26, 2011) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the second annual Advanced Techniques in Transoral Fundoplication CME course will be held February 3-4 in Denver, CO. Tailored to the needs of physicians and OR/GI staff with an interest in the transoral approach |
| EndoGastric Solutions Achieves 5,000 NOS Cases Milestone |
| September 30, 2010 |
| Redwood City, CA (September 30, 2010) — EndoGastric Solutions (EGS),the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that 5,000 NOS procedures have been completed worldwide using the company’s innovative EsophyX and StomaphyX technologies. Procedure momentum has been accelerating, with nearly half the procedures performed |
| EndoGastric Solutions Completes $30 Million Financing Round |
| August 30, 2010 |
| Redwood City, CA (August 30, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Canaan Partners and Radius Ventures co-led a $30 Million Series F financing designed to support the company through profitability. Existing investors Advanced Technology Ventures, MPM Capital, Foundation Medical |
| EndoGastric Solutions Announces the Appointment of Floyd Loop, M.D., to Its Board of Directors |
| August 25, 2010 |
| Redwood City, CA (August 25, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that Floyd D. Loop, M.D., has joined its Board of Directors. “Dr. Loop is the ideal individual to join our Board of Directors at this stage in the company’s evolution,” said Thierry Thaure, President and Chief Executive Officer |
| EndoGastric Solutions Announces Launch of TIF Registry |
| May 10, 2010 |
| Redwood City, CA (April 28, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced the launch of the TIF (Transoral Incisionless Fundoplication) Registry Study. |
NP01937-01A
